Business in Brief
October 27, 2020
The latest industry news, appointments and acquisitions – in 65 words or less
1 min read
False
Advertisement
March 2017
Welcome to March’s issue. Upfront’s topics range from infant cataract surgery to a myopia cell, and In My View sees Harry Quigley make the case for better measures of doctors’ success. Our Features take an in-depth look at what could be refractive surgery’s Holy Grail – eyedrops for presbyopia and explore the quest to develop non-invasive biomechanical assessments of the eye, and shares opinions from leading experts in the field. In Practice introduces a new surgical technique for advanced keratoconus, and NextGen features an overview of bone marrow stem cells for retinal disorders. In Profession, two experts discuss what healthcare changes under Trump might mean for ophthalmology. Finally, we Sit Down With Mark Baum and Martine Jager.
Progressive Optics for Impressive Outcomes
March 9, 2017
The SIFI Mini WELL IOL provides a progressive, extended depth-of-focus experience for patients – not just a few sharp foci. How is this achieved? What does this mean for patients? And who are the best candidates? Gerd Auffarth shares his thoughts.
1 min read
The Hubble Telescope of the Eye
March 8, 2017
The quest for truly non-invasive ocular biomechanical measurements
1 min read
Like Einstein, Question Everything
March 8, 2017
Advances aren’t made by following dogma, but by interrogating it
1 min read
Stop! Collaborate and Listen
March 8, 2017
Sitting Down With... Martine Jager, Professor, Leiden University Medical Centre, The Netherlands.
1 min read
An Issue of Inequity
March 8, 2017
Poorer people suffer poorer outcomes across all of medicine. Can eyecare buck the trend?
1 min read
An Arm and a Leg
March 3, 2017
Sitting Down With... Mark Baum, founder and CEO of Imprimis Pharmaceuticals.
1 min read
From Obamacare to Trumpcare
March 3, 2017
For now, the future of healthcare remains uncertain – but what are the potential outcomes for ophthalmology?
1 min read
Benchmarking Dry AMD
March 3, 2017
What does analysis of the last five years of dry AMD literature tell us about the priorities of the field and its major contributors?
1 min read
It’s in Their Bones
March 3, 2017
Bone marrow stem cells for the treatment of retinal disease? They’re closer to the clinic than you might think
1 min read
Bowman + Bulk = Better Results
March 3, 2017
Mid-stromal lamellar keratoplasty (MSLK) is a new surgical technique for the management of advanced keratoconus
1 min read
A-peeling Approach?
March 2, 2017
I currently perform ILM peeling for macular holes, but recent research suggests peeling in all cases is not necessary – or without risk
1 min read
Rupture Risk
March 2, 2017
Mounting evidence suggests intravitreal injections increase the risk of posterior capsule rupture during cataract surgery, but why?
1 min read
Peptide Power
March 2, 2017
Could a small biomimetic peptide be a promising alternative to anti-VEGF treatment?
1 min read
ON Delayed Gratification
March 2, 2017
Could a newly identified retinal ganglion cell type unlock the mystery of myopia?
1 min read
It’s Good to Talk
March 2, 2017
What patients report versus what physicians record can be substantially different – with far-reaching implications for EMR-based research
1 min read
How Good a Doctor Are You?
March 2, 2017
Your income may depend on it… but we have no real way to measure what actually matters to patients
1 min read
Ctrl + Shift + IOL
March 2, 2017
Controlling for myopic shift following cataract surgery in infants: too many variables?
1 min read
OCT for all, and all for OCT
February 1, 2017
Eye exams can detect more than ocular disease. Is there a place for it in general practice?
1 min read
Browse by Subspecialties
False
Advertisement